Other News

Marizyme, Inc. Expands Executive Team, Board of Directors

Steven Brooks, M.D., MBA, FACC – Appointed EVP of Medical and Regulatory Affairs, Chief Medical Officer Donald Very, Ph.D. – Appointed EVP, Research & Development William Hearl, Ph.D. – Named Independent Member of Board of Directors JUPITER, Fla., Dec. 4, 2020 /PRNewswire/ — Marizyme, Inc. (OTCQB: MRZM), a publicly traded global biotechnology company developing products […]

LivaNova and Gyrus Capital Enter into Agreement for the Purchase of Heart Valve Business

LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, and Gyrus Capital (Gyrus), an investment firm dedicated to investments in the healthcare and sustainability sectors, today announced they have entered into an agreement whereby entities funded and controlled by Gyrus will acquire the LivaNova heart valve (HV) business. […]

Aidoc and Imbio partner to provide an industry first AI solution to prioritize suspected pulmonary embolism and automatically calculate RV/LV ratio

NEW YORK, Dec. 3, 2020 /PRNewswire/ — Aidoc, the leading provider of enterprise AI solutions, and Imbio, a leading provider of medical image analysis for pulmonary and cardiothoracic diseases, announced today a partnership intended to provide the world’s first end-to-end AI solution for pulmonary embolism (PE), with the goal of ultimately improving efficiency and quality […]

BIOMODEX Names Bill Perusek as Vice President of U.S. Sales

Former sales leader at Corindus Vascular Robotics and Boston Scientific joins Biomodex to head up U.S. sales of growing portfolio of 3D printed solutions for patient-specific rehearsal and physician training BOSTON, Dec. 3, 2020 /PRNewswire/ — BIOMODEX®, a pioneering digital health company that offers unique and enhanced 3D printed solutions for patient-specific rehearsal […]

CVRx® BAROSTIM Therapy Receives CMS Approval for Transitional Pass-Through Payment Status

Incremental Reimbursement in Outpatient Setting Will Expand Availability of the Breakthrough BAROSTIM Therapy Heart Failure Treatment MINNEAPOLIS, Dec. 03, 2020 (GLOBE NEWSWIRE) — CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced that the Centers for Medicare and Medicaid Services (CMS) granted […]

Canon Medical’s Premium Ultrasound Platform Allows for Easy, Fast Scanning with New Advancements

Updates on Aplio i-series Offer Depth and Detail in Imaging with Enhanced Comfort to Help Improve Workflow TUSTIN, Calif.–(BUSINESS WIRE)–Continuing to push the envelope with advanced ultrasound depth and detail plus ultimate comfort features for enhanced sonographer workflow, Canon Medical Systems USA, Inc. will showcase its premium Aplio i-series ultrasound platform with new design […]

Canon Medical’s All-New 12×16 Hi-Def Imaging Detector Provides Highest Resolution in the Market to Help Clinicians See Fine Details

New Detector Size Can Help Improve Visualization During Peripheral and Abdominal Procedures TUSTIN, Calif.–(BUSINESS WIRE)–Continuing its focus on providing clinicians with clarity and precision during vascular and IR procedures without compromising dose, Canon Medical Systems USA, Inc. is introducing an all-new size for its Hi-Def flat panel detector. The 12×16 Hi-Def detector […]

Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with DongWha Pharm

Quantum Genomics to receive up to $18.5 million in upfront and milestone payments plus double-digit royalties on sales DongWha Pharm to receive an exclusive license to develop and commercialize firibastat for the treatment of difficult to treat/resistant hypertension in South Korea PARIS, Dec. 02, 2020 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical […]

V-Wave Announces Appointment of Bill Hughes as Chief Financial Officer

Seasoned Medical Device Executive Joins Breakthrough Structural Heart Company CAESAREA, Israel and AGOURA HILLS, Calif., Dec. 2, 2020 /PRNewswire/ — V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive interatrial shunt devices for treating patients with severe symptomatic heart failure (HF) and pulmonary arterial hypertension (PAH), announced the appointment of Bill Hughes as its Chief Financial […]